• The scheme is open to researchers in all faculties and institutes of the University of Tasmania; departments within Tasmanian hospitals; and the Department of Health and Human Services.
• The research must focus on leukaemia, lymphoma or blood related diseases.
• It includes population health strategies, medical research, clinical and psychosocial care
• An individual can only be listed on one grant as a lead chief investigator (CI) at any one time. Achievement of deliverables on previous DCLFtas grants will be considered when assessing requests.
• Closing date and time of the scheme, formatting length and supporting documentation requirements must be strictly adhered to. Applicants not meeting these requirements will not be eligible for funding.

• Quality of the research proposal, including feasibility and budget (50%)
• Research capacity, including track record and research team (25%)
• Applications with an early career researcher as the lead investigator will receive additional 20% weighting in this category. Please indicate on the form if you are an early career researcher. This includes those who obtained their PhD or highest degree ≤ 5 FTE years ago or who have had no grants as a lead investigator (>$10,000). If you are unsure whether you meet this criterion, please contact DCLFtas.
• Research significance and innovation, including alignment with the strategic direction of DCLFtas and broader contribution to the field of research (25%).

• Full electronic applications must be submitted to enquiries@DCLFtas.org.au
• Applications will be distributed to the relevant review panel.
• Members of the panel will individually assess, score and rank applications.
• Ranked applications will then be discussed at a DCLFtas meeting to consolidate a score and ranking.
• The committee of DCLFtas will then make a funding recommendation.
• Applicants will be informed of their outcome.

• The term of each funding round will be 12 months.
• Research funding must be spent, as outlined in the application, by the project close date. Unspent funds will be reclaimed.
• A Final Report must be submitted.
• No part of the funding is to be used for external conference attendance.
• If a sole CI leaves their current employment, then the grant must be relinquished.
• Funding cannot be used for salaries, or to fund a Research Higher Degree candidate’s stipend or fees.
• Funding is subject to investigators obtaining relevant ethics committee approvals.

• Include: Project Title; aims and hypotheses; research plan, including background and methods; timeline, including likely outputs within a 24 month period; and budget.

• How does your project align with the current strategic direction of DCLFtas?
• How is your project significant and/or innovative in relation to the broader field of research?

• A list of publications and grants (include title of project, investigators, funding body, total amount, years funded) within the last 6 years (including the first 6 months of this current year).
• A track record statement for the CI’s team
• Description of key research outputs including most significant publications and those that demonstrate collaboration between team members
• Contribution to discipline or area, which includes, but is not limited to, invitations to speak at meetings, conferences or contributions to development of policy or clinical guidelines
• Other research-related achievements. These could include influence on policy or practice or community engagement

Note: These categories align with those requested for project grants by the NMRC

• Research capacity is assessed for the last 6 years, including the first 6 months of the current year.
• Career interruptions can be detailed in a separate attachment.

1. List of publications and grants in the previous 6 years
2. Track record statement(s)
3. Career disruptions